Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapyplus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy withNivolumab or Nivolumab and BMS-986205 in Participants with

  • Rao, Arpit (PI)
  • Gupta, Shilpa (Prior Principal Investigator)

Project: Research project

Project Details

Description

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with
StatusFinished
Effective start/end date11/1/18 → 11/30/23

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint